The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 15, 2022

Filed:

Dec. 09, 2016
Applicant:

Alk-abelló, Inc., Bedminster, NJ (US);

Inventors:

Scott H. Coleman, San Diego, CA (US);

Wei-Cheng Liaw, San Diego, CA (US);

Jerry Wroblewski, San Mateo, CA (US);

Robert Savel, San Diego, CA (US);

Assignee:

ALK-ABELLÓ, INC., Bedminster, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61P 27/16 (2006.01); A61K 31/496 (2006.01); A61K 47/34 (2017.01); A61K 9/00 (2006.01); A61K 47/10 (2017.01); A61F 15/00 (2006.01); A61M 5/00 (2006.01); A61M 5/178 (2006.01); A61M 5/32 (2006.01); A61M 31/00 (2006.01); A61K 9/14 (2006.01); A61B 46/20 (2016.01); A61F 7/10 (2006.01);
U.S. Cl.
CPC ...
A61K 31/496 (2013.01); A61F 15/001 (2013.01); A61K 9/00 (2013.01); A61K 9/0019 (2013.01); A61K 9/0046 (2013.01); A61K 47/10 (2013.01); A61K 47/34 (2013.01); A61M 5/002 (2013.01); A61M 5/1782 (2013.01); A61M 5/329 (2013.01); A61M 31/002 (2013.01); A61P 27/16 (2018.01); A61B 46/20 (2016.02); A61F 2007/108 (2013.01); A61K 9/14 (2013.01); A61M 2210/0668 (2013.01);
Abstract

Disclosed herein are otic product kits for administration of a sterilized formulation. In some embodiments, the otic product kit comprises: an aseptic container containing the sterilized formulation; a syringe; and an administration needle connectable to the syringe, wherein the sterilized formulation comprising: from about 5.5 wt % to about 6.5 wt % multiparticulate ciprofloxacin; from about 15 wt % to about 17 wt % poloxamer 407; and water. Also disclosed herein are methods of preparing and administrating the sterilized formulation. In some embodiments, the method comprising (1) transferring the sterilized otic formulation from an aseptic container to a syringe through a preparation needle; (2) replacing the preparation needle with an administration needle; and (3) injecting the sterilized otic formulation from the syringe through the administration needle into the ear of a patient.


Find Patent Forward Citations

Loading…